Allergan backed out of a deal to merger with Salix Pharmaceuticals, which would have likely stymied Valeant's hostile takeover, after it found out that Salix has enough inventory to last months, not weeks.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/13RYNkx
Cap comentari:
Publica un comentari a l'entrada